Shirishkumar Kulkarni

USPTO Granted Patents = 14 (Patent Applications = 15)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 26)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 57(Granted Patents)

Location History:

Pune, IN (2013 - 2020)
Maharashtra, IN (2016 - 2022)

Company Filing History:

Medicis Pharmaceutical Corporation

patents

Years Active: 2013-2022

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11278502 - Modified release formulation of lacosamide (2022-03-22),

2. 10842802 - Controlled release pharmaceutical dosage forms (2020-11-24),

3. 10786464 - Modified release formulation of lacosamide (2020-09-29),

4. 10137114 - Rifaximin ready-to-use suspension (2018-11-27),

5. 9931405 - Pharmaceutical compositions for gastrointestinal drug delivery (2018-04-03),

6. 9884022 - Controlled release pharmaceutical compositions of tapentadol (2018-02-06),

7. 9820936 - Oral controlled release pharmaceutical compositions of Bepotastine (2017-11-21),

8. 9421165 - Oral controlled release pharmaceutical compositions of bepotastine (2016-08-23),

9. 9211258 - Rifaximin ready-to-use suspension (2015-12-15),

10. 9040089 - Oral compositions of clindamycin (2015-05-26),

11. 8974825 - Pharmaceutical compositions for gastrointestinal drug delivery (2015-03-10),

12. 8916194 - Controlled release pharmaceutical compositions of milnacipran (2014-12-23),

13. 8614210 - Process for preparing pharmaceutical ophthalmic compositions (2013-12-24),

14. 8383151 - Pharmaceutical compositions of rifaximin (2013-02-26),

Title: Shirishkumar Kulkarni: Innovator in Pharmaceutical Formulations

Introduction

Shirishkumar Kulkarni is a prominent inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 14 patents. His work focuses on developing innovative drug delivery systems that enhance the efficacy of medications.

Latest Patents

Among his latest patents is a modified release formulation of lacosamide. This invention provides a modified release formulation that includes lacosamide and a modified release polymer, ensuring minimal peak-to-trough variation over a period of at least 12 hours. Another notable patent is for controlled release pharmaceutical dosage forms, which includes novel methods of making and using these forms to treat dermatological conditions.

Career Highlights

Shirishkumar has worked with reputable companies such as Lupin, Inc. and Medicis Pharmaceutical Corporation. His experience in these organizations has allowed him to refine his skills in pharmaceutical research and development.

Collaborations

Some of his notable coworkers include Harshal Jahagirdar and Ashish Ashokrao Deshmukh. Their collaboration has contributed to the advancement of innovative pharmaceutical solutions.

Conclusion

Shirishkumar Kulkarni's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the field. His patents reflect a dedication to improving drug delivery systems for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.